Form 4: Surgery Partners Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Anthony Taparo, Chief Growth Officer of Surgery Partners, Inc., sold 1,347 shares of common stock on March 5, 2024, to cover tax obligations related to vesting restricted stock.
Summary
- On March 5, 2024, Anthony Taparo, the Chief Growth Officer of Surgery Partners, Inc., sold 1,347 shares of the company's common stock.
- The sale was executed at a weighted average price of $30.7 per share.
- This transaction was to satisfy tax withholding obligations related to the vesting of restricted stock on March 2, 2024.
- Following the transaction, Taparo directly owns 103,759 shares of Surgery Partners, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an insider stock sale for tax purposes. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common reason for such transactions.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/02/2024 | Restricted stock vested, triggering tax obligations. |
| 03/05/2024 | Date of stock sale by Anthony Taparo. |
| 03/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.